352
Views
6
CrossRef citations to date
0
Altmetric
Review

Between Curing and Torturing: Burden of Adverse Reaction in Drug-Resistant Tuberculosis Therapy

ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 2597-2607 | Published online: 23 Nov 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Dhivya L. S.Kathiravan M. K.Gopalakrishnan Thamilselvan. (2023) Design, synthesis and anti-Tb evaluation of chalcone derivatives as novel inhibitors of InhA. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-12.
Read now

Articles from other publishers (5)

Zeynep Yegin Katran, İsmet Bulut, Aylin Babalık, Metin Keren, Fatma Merve Tepetam, Selver Seda Mersin, Cihan Örçen, Tuğçe Yakut & Dilek Yavuz. (2023) Drug hypersensitivity in drug-resistant tuberculosis. World Allergy Organization Journal 16:5, pages 100778.
Crossref
Suyash M. Patil, Druva Sarika Barji, Tejashri Chavan, Kinjal Patel, Andrew J. Collazo, Vasudha Prithipaul, Aaron Muth & Nitesh K. Kunda. (2023) Solubility Enhancement and Inhalation Delivery of Cyclodextrin-Based Inclusion Complex of Delamanid for Pulmonary Tuberculosis Treatment. AAPS PharmSciTech 24:1.
Crossref
Yangming Ding, Hui Zhu, Lei Fu, Weiyan Zhang, Bin Wang, Shaochen Guo, Xi Chen, Ning Wang, Haiting Liu & Yu Lu. (2022) Superior Efficacy of a TBI-166, Bedaquiline, and Pyrazinamide Combination Regimen in a Murine Model of Tuberculosis. Antimicrobial Agents and Chemotherapy 66:9.
Crossref
Harsh Shah, Sandul Yasobant, Jay Patel, Priya Bhavsar, Somen Saha, Yogesh Patel, Deepak Saxena & Anish Sinha. (2022) Characteristics and contributing factors of adverse drug reactions: an analytical study of patients with tuberculosis receiving treatment under the National TB Program of India. F1000Research 11, pages 1388.
Crossref
Ionela-Alina Grosu-Creangă, Antigona Carmen Trofor, Radu Adrian Crișan-Dabija, Daniela Robu-Popa, Cristina Mihaela Ghiciuc & Elena Cătălina Lupușoru. (2021) Adverse effects induced by second-line antituberculosis drugs: an update based on last WHO treatment recommendations for drug-resistant tuberculosis. Pneumologia 70:3, pages 117-126.
Crossref